These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15854059)

  • 41. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.
    Frezzolini A; Teofoli P; Cianchini G; Barduagni S; Ruffelli M; Ferranti G; Puddu P; De Pita O
    Eur J Dermatol; 2002; 12(1):27-31. PubMed ID: 11809592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunoglobulins in atopic eczema and psoriasis].
    Chaloupecká O; Kostka J; Kohout P; Petrovský J
    Cesk Dermatol; 1974 Oct; 49(5):290-2. PubMed ID: 4429983
    [No Abstract]   [Full Text] [Related]  

  • 43. [Disorders of T-cell immunity in patients with eczema, atopic dermatitis and psoriasis].
    Khazizov IE
    Klin Med (Mosk); 1991 Oct; 69(10):36-40. PubMed ID: 1837323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4.
    Tamagawa-Mineoka R; Katoh N; Ueda E; Masuda K; Kishimoto S
    Allergol Int; 2008 Dec; 57(4):391-6. PubMed ID: 18797178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of different circulating autoantibodies in patients with bullous pemphigoid and pemphigus vulgaris by means of immunoblotting.
    Kiss M; Husz S; Molnár K; Dobozy A
    Acta Microbiol Immunol Hung; 1996; 43(2-3):115-23. PubMed ID: 8876727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bullous pemphigoid in a patient with psoriasis and possible drug reaction: a case report.
    Paul J
    Conn Med; 2004; 68(10):611-5. PubMed ID: 15626136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dohi memorial lecture. Leukocytes and skin disease: conflicting patterns of inflammation in atopic dermatitis and psoriasis.
    Christophers E
    J Dermatol; 1986 Dec; 13(6):408-16. PubMed ID: 3549819
    [No Abstract]   [Full Text] [Related]  

  • 48. Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis.
    Yoshida K; Kubo A; Fujita H; Yokouchi M; Ishii K; Kawasaki H; Nomura T; Shimizu H; Kouyama K; Ebihara T; Nagao K; Amagai M
    J Allergy Clin Immunol; 2014 Oct; 134(4):856-64. PubMed ID: 25282566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bullous pemphigoid occurring during efalizumab treatment for psoriasis: a paradoxical auto-immune reaction?
    Monnier-Murina K; Du Thanh A; Merlet-Albran S; Guillot B; Dereure O
    Dermatology; 2009; 219(1):89-90. PubMed ID: 19270438
    [No Abstract]   [Full Text] [Related]  

  • 50. [Subpopulations of peripheral T lymphocytes (Th/Ts) in atopic dermatitis and in psoriasis].
    Klene U; Gollnick H; Bauer R; Orfanos CE
    Hautarzt; 1986 Jan; 37(1):17-22. PubMed ID: 2936698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case of generalized pustular psoriasis followed by bullous disease: an atypical case of bullous pemphigoid or a novel bullous disease?
    Saeki H; Hayashi N; Komine M; Soma Y; Shimada S; Watanabe K; Hashimoto T
    Br J Dermatol; 1996 Jan; 134(1):152-5. PubMed ID: 8745904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endocrine stress responses in TH1-mediated chronic inflammatory skin disease (psoriasis vulgaris)--do they parallel stress-induced endocrine changes in TH2-mediated inflammatory dermatoses (atopic dermatitis)?
    Buske-Kirschbaum A; Ebrecht M; Kern S; Hellhammer DH
    Psychoneuroendocrinology; 2006 May; 31(4):439-46. PubMed ID: 16359823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bullous pemphigoid and psoriasis vulgaris.
    Burnett PE
    Dermatol Online J; 2003 Oct; 9(4):19. PubMed ID: 14594592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Down-regulation of atopic dermatitis-associated serum chemokines by wet-wrap treatment: a pilot study.
    Ong PY; Ferdman RM; Dunaway T; Church JA; Inderlied CB
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):286-7. PubMed ID: 18426151
    [No Abstract]   [Full Text] [Related]  

  • 55. [Bullous pemphigoid precipitated by PUVA therapy].
    Bastian P; Drobacheff C; Laurent R
    Ann Dermatol Venereol; 1990; 117(10):734. PubMed ID: 2073069
    [No Abstract]   [Full Text] [Related]  

  • 56. Delayed onset of bullous pemphigoid after PUVA and sunlight treatment of psoriasis.
    Albergo RP; Gilgor RS
    Cutis; 1982 Nov; 30(5):621-4. PubMed ID: 6756797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy.
    Kwon YS; Oh SH; Wu WH; Bae BG; Lee HJ; Lee MG; Lee KH
    Exp Dermatol; 2010 Mar; 19(3):246-51. PubMed ID: 19758316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis.
    Gerdes S; Kurrat W; Mrowietz U
    Br J Dermatol; 2009 Apr; 160(4):736-40. PubMed ID: 19076976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atopic dermatitis: Age and race do matter!
    Leung DY
    J Allergy Clin Immunol; 2015 Nov; 136(5):1265-7. PubMed ID: 26549637
    [No Abstract]   [Full Text] [Related]  

  • 60. T-cell phenotyping uncovers systemic features of atopic dermatitis and psoriasis.
    Farrera C; Melchiotti R; Petrov N; Weng Teng KW; Wong MT; Loh CY; Villanova F; Tosi I; Chen J; Grys K; Sreeneebus H; Chapman A; Perera GK; Heck S; Gracio F; de Rinaldis E; Barker JN; Smith CH; Nestle FO; Newell EW; Di Meglio P
    J Allergy Clin Immunol; 2020 Mar; 145(3):1021-1025.e15. PubMed ID: 31812571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.